Sigrima 420 mg Injection (pertuzumab) is a targeted therapy used primarily to treat HER2-positive breast cancer, including early-stage and metastatic forms. It works by binding to HER2 receptors, inhibiting tumor growth, and inducing cell death (apoptosis), often used in combination with trastuzumab and chemotherapy to improve survival.